nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—prostate cancer—Betamethasone—psoriatic arthritis	0.32	0.387	CpDpCtD
Metoclopramide—prostate cancer—Dexamethasone—psoriatic arthritis	0.32	0.387	CpDpCtD
Metoclopramide—migraine—Prednisone—psoriatic arthritis	0.186	0.225	CpDpCtD
Metoclopramide—CYP17A1—Dexamethasone—psoriatic arthritis	0.126	0.928	CbGbCtD
Metoclopramide—CYP2D6—Dexamethasone—psoriatic arthritis	0.0098	0.072	CbGbCtD
Metoclopramide—Neutropenia—Auranofin—psoriatic arthritis	0.000733	0.019	CcSEcCtD
Metoclopramide—Menstruation irregular—Prednisolone—psoriatic arthritis	0.00072	0.0186	CcSEcCtD
Metoclopramide—Jaundice—Auranofin—psoriatic arthritis	0.000682	0.0176	CcSEcCtD
Metoclopramide—Menstruation irregular—Triamcinolone—psoriatic arthritis	0.000662	0.0171	CcSEcCtD
Metoclopramide—Menstruation irregular—Methylprednisolone—psoriatic arthritis	0.000661	0.0171	CcSEcCtD
Metoclopramide—Agranulocytosis—Auranofin—psoriatic arthritis	0.000653	0.0169	CcSEcCtD
Metoclopramide—Visual impairment—Auranofin—psoriatic arthritis	0.000605	0.0157	CcSEcCtD
Metoclopramide—Menstruation irregular—Betamethasone—psoriatic arthritis	0.000601	0.0155	CcSEcCtD
Metoclopramide—Menstruation irregular—Dexamethasone—psoriatic arthritis	0.000601	0.0155	CcSEcCtD
Metoclopramide—Menstruation irregular—Prednisone—psoriatic arthritis	0.000523	0.0135	CcSEcCtD
Metoclopramide—Suicidal ideation—Methylprednisolone—psoriatic arthritis	0.000522	0.0135	CcSEcCtD
Metoclopramide—Mania—Methylprednisolone—psoriatic arthritis	0.000503	0.013	CcSEcCtD
Metoclopramide—Angioedema—Auranofin—psoriatic arthritis	0.000499	0.0129	CcSEcCtD
Metoclopramide—Leukopenia—Auranofin—psoriatic arthritis	0.000489	0.0127	CcSEcCtD
Metoclopramide—Suicidal ideation—Betamethasone—psoriatic arthritis	0.000474	0.0123	CcSEcCtD
Metoclopramide—Suicidal ideation—Dexamethasone—psoriatic arthritis	0.000474	0.0123	CcSEcCtD
Metoclopramide—Mania—Betamethasone—psoriatic arthritis	0.000457	0.0118	CcSEcCtD
Metoclopramide—Mania—Dexamethasone—psoriatic arthritis	0.000457	0.0118	CcSEcCtD
Metoclopramide—Amenorrhoea—Methylprednisolone—psoriatic arthritis	0.000416	0.0108	CcSEcCtD
Metoclopramide—Suicidal ideation—Prednisone—psoriatic arthritis	0.000413	0.0107	CcSEcCtD
Metoclopramide—Mania—Prednisone—psoriatic arthritis	0.000398	0.0103	CcSEcCtD
Metoclopramide—Amenorrhoea—Dexamethasone—psoriatic arthritis	0.000379	0.0098	CcSEcCtD
Metoclopramide—Amenorrhoea—Betamethasone—psoriatic arthritis	0.000379	0.0098	CcSEcCtD
Metoclopramide—Fluid retention—Prednisolone—psoriatic arthritis	0.000378	0.00979	CcSEcCtD
Metoclopramide—Wheezing—Triamcinolone—psoriatic arthritis	0.000356	0.00921	CcSEcCtD
Metoclopramide—Urticaria—Auranofin—psoriatic arthritis	0.000354	0.00917	CcSEcCtD
Metoclopramide—Fluid retention—Triamcinolone—psoriatic arthritis	0.000348	0.00901	CcSEcCtD
Metoclopramide—Fluid retention—Methylprednisolone—psoriatic arthritis	0.000347	0.00899	CcSEcCtD
Metoclopramide—Delirium—Prednisone—psoriatic arthritis	0.000337	0.00872	CcSEcCtD
Metoclopramide—Amenorrhoea—Prednisone—psoriatic arthritis	0.00033	0.00853	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Prednisolone—psoriatic arthritis	0.000319	0.00826	CcSEcCtD
Metoclopramide—Fluid retention—Betamethasone—psoriatic arthritis	0.000316	0.00817	CcSEcCtD
Metoclopramide—Fluid retention—Dexamethasone—psoriatic arthritis	0.000316	0.00817	CcSEcCtD
Metoclopramide—Hepatotoxicity—Methotrexate—psoriatic arthritis	0.000314	0.00811	CcSEcCtD
Metoclopramide—Visual disturbance—Prednisolone—psoriatic arthritis	0.000305	0.0079	CcSEcCtD
Metoclopramide—Diarrhoea—Auranofin—psoriatic arthritis	0.000305	0.0079	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Triamcinolone—psoriatic arthritis	0.000293	0.00759	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Methylprednisolone—psoriatic arthritis	0.000293	0.00758	CcSEcCtD
Metoclopramide—Rash—Auranofin—psoriatic arthritis	0.000281	0.00728	CcSEcCtD
Metoclopramide—Dermatitis—Auranofin—psoriatic arthritis	0.000281	0.00727	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisolone—psoriatic arthritis	0.000275	0.00712	CcSEcCtD
Metoclopramide—Fluid retention—Prednisone—psoriatic arthritis	0.000275	0.00712	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Dexamethasone—psoriatic arthritis	0.000266	0.00689	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Betamethasone—psoriatic arthritis	0.000266	0.00689	CcSEcCtD
Metoclopramide—Nausea—Auranofin—psoriatic arthritis	0.000265	0.00686	CcSEcCtD
Metoclopramide—Visual disturbance—Betamethasone—psoriatic arthritis	0.000255	0.00659	CcSEcCtD
Metoclopramide—Visual disturbance—Dexamethasone—psoriatic arthritis	0.000255	0.00659	CcSEcCtD
Metoclopramide—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.000253	0.00655	CcSEcCtD
Metoclopramide—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.000252	0.00653	CcSEcCtD
Metoclopramide—Respiratory failure—Methotrexate—psoriatic arthritis	0.000247	0.00638	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Prednisone—psoriatic arthritis	0.000232	0.006	CcSEcCtD
Metoclopramide—Asthma—Triamcinolone—psoriatic arthritis	0.00023	0.00595	CcSEcCtD
Metoclopramide—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00023	0.00594	CcSEcCtD
Metoclopramide—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00023	0.00594	CcSEcCtD
Metoclopramide—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.000226	0.00584	CcSEcCtD
Metoclopramide—Gynaecomastia—Methotrexate—psoriatic arthritis	0.000217	0.00561	CcSEcCtD
Metoclopramide—Bradycardia—Prednisolone—psoriatic arthritis	0.000204	0.00527	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisone—psoriatic arthritis	0.0002	0.00517	CcSEcCtD
Metoclopramide—Visual impairment—Prednisolone—psoriatic arthritis	0.000193	0.00499	CcSEcCtD
Metoclopramide—Bradycardia—Triamcinolone—psoriatic arthritis	0.000187	0.00485	CcSEcCtD
Metoclopramide—Bradycardia—Methylprednisolone—psoriatic arthritis	0.000187	0.00484	CcSEcCtD
Metoclopramide—Visual disturbance—Methotrexate—psoriatic arthritis	0.000185	0.0048	CcSEcCtD
Metoclopramide—Hallucination—Methylprednisolone—psoriatic arthritis	0.000183	0.00473	CcSEcCtD
Metoclopramide—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000177	0.00458	CcSEcCtD
Metoclopramide—Bradycardia—Dexamethasone—psoriatic arthritis	0.00017	0.0044	CcSEcCtD
Metoclopramide—Bradycardia—Betamethasone—psoriatic arthritis	0.00017	0.0044	CcSEcCtD
Metoclopramide—Neutropenia—Prednisone—psoriatic arthritis	0.00017	0.0044	CcSEcCtD
Metoclopramide—Erectile dysfunction—Prednisone—psoriatic arthritis	0.000167	0.00433	CcSEcCtD
Metoclopramide—Hallucination—Betamethasone—psoriatic arthritis	0.000166	0.0043	CcSEcCtD
Metoclopramide—Hallucination—Dexamethasone—psoriatic arthritis	0.000166	0.0043	CcSEcCtD
Metoclopramide—Depression—Prednisone—psoriatic arthritis	0.000162	0.00418	CcSEcCtD
Metoclopramide—Visual impairment—Betamethasone—psoriatic arthritis	0.000161	0.00417	CcSEcCtD
Metoclopramide—Visual impairment—Dexamethasone—psoriatic arthritis	0.000161	0.00417	CcSEcCtD
Metoclopramide—Angioedema—Prednisolone—psoriatic arthritis	0.000159	0.00412	CcSEcCtD
Metoclopramide—Asthma—Methotrexate—psoriatic arthritis	0.000152	0.00393	CcSEcCtD
Metoclopramide—Convulsion—Prednisolone—psoriatic arthritis	0.000151	0.00391	CcSEcCtD
Metoclopramide—Hypertension—Prednisolone—psoriatic arthritis	0.00015	0.00389	CcSEcCtD
Metoclopramide—Bradycardia—Prednisone—psoriatic arthritis	0.000148	0.00383	CcSEcCtD
Metoclopramide—Angioedema—Triamcinolone—psoriatic arthritis	0.000146	0.00379	CcSEcCtD
Metoclopramide—Angioedema—Methylprednisolone—psoriatic arthritis	0.000146	0.00378	CcSEcCtD
Metoclopramide—Hallucination—Prednisone—psoriatic arthritis	0.000145	0.00375	CcSEcCtD
Metoclopramide—Oedema—Prednisolone—psoriatic arthritis	0.000142	0.00368	CcSEcCtD
Metoclopramide—Neutropenia—Methotrexate—psoriatic arthritis	0.000142	0.00368	CcSEcCtD
Metoclopramide—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00014	0.00362	CcSEcCtD
Metoclopramide—Convulsion—Triamcinolone—psoriatic arthritis	0.000139	0.00359	CcSEcCtD
Metoclopramide—Tachycardia—Prednisolone—psoriatic arthritis	0.000139	0.00359	CcSEcCtD
Metoclopramide—Convulsion—Methylprednisolone—psoriatic arthritis	0.000139	0.00359	CcSEcCtD
Metoclopramide—Hypertension—Triamcinolone—psoriatic arthritis	0.000138	0.00358	CcSEcCtD
Metoclopramide—Hypertension—Methylprednisolone—psoriatic arthritis	0.000138	0.00357	CcSEcCtD
Metoclopramide—Anxiety—Methylprednisolone—psoriatic arthritis	0.000136	0.00351	CcSEcCtD
Metoclopramide—Drowsiness—Methotrexate—psoriatic arthritis	0.000135	0.0035	CcSEcCtD
Metoclopramide—Depression—Methotrexate—psoriatic arthritis	0.000135	0.00349	CcSEcCtD
Metoclopramide—Flushing—Prednisone—psoriatic arthritis	0.000135	0.00349	CcSEcCtD
Metoclopramide—Angioedema—Dexamethasone—psoriatic arthritis	0.000133	0.00344	CcSEcCtD
Metoclopramide—Angioedema—Betamethasone—psoriatic arthritis	0.000133	0.00344	CcSEcCtD
Metoclopramide—Confusional state—Methylprednisolone—psoriatic arthritis	0.000132	0.00341	CcSEcCtD
Metoclopramide—Oedema—Triamcinolone—psoriatic arthritis	0.000131	0.00338	CcSEcCtD
Metoclopramide—Insomnia—Prednisolone—psoriatic arthritis	0.000129	0.00333	CcSEcCtD
Metoclopramide—Tachycardia—Triamcinolone—psoriatic arthritis	0.000128	0.0033	CcSEcCtD
Metoclopramide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000127	0.0033	CcSEcCtD
Metoclopramide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000126	0.00327	CcSEcCtD
Metoclopramide—Convulsion—Betamethasone—psoriatic arthritis	0.000126	0.00326	CcSEcCtD
Metoclopramide—Convulsion—Dexamethasone—psoriatic arthritis	0.000126	0.00326	CcSEcCtD
Metoclopramide—Hypertension—Dexamethasone—psoriatic arthritis	0.000126	0.00325	CcSEcCtD
Metoclopramide—Hypertension—Betamethasone—psoriatic arthritis	0.000126	0.00325	CcSEcCtD
Metoclopramide—Anxiety—Dexamethasone—psoriatic arthritis	0.000123	0.00319	CcSEcCtD
Metoclopramide—Anxiety—Betamethasone—psoriatic arthritis	0.000123	0.00319	CcSEcCtD
Metoclopramide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000122	0.00316	CcSEcCtD
Metoclopramide—Oedema—Betamethasone—psoriatic arthritis	0.000119	0.00307	CcSEcCtD
Metoclopramide—Oedema—Dexamethasone—psoriatic arthritis	0.000119	0.00307	CcSEcCtD
Metoclopramide—Insomnia—Triamcinolone—psoriatic arthritis	0.000118	0.00306	CcSEcCtD
Metoclopramide—Insomnia—Methylprednisolone—psoriatic arthritis	0.000118	0.00305	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000117	0.00303	CcSEcCtD
Metoclopramide—Visual impairment—Methotrexate—psoriatic arthritis	0.000117	0.00303	CcSEcCtD
Metoclopramide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000117	0.00302	CcSEcCtD
Metoclopramide—Agitation—Prednisone—psoriatic arthritis	0.000116	0.00301	CcSEcCtD
Metoclopramide—Tachycardia—Dexamethasone—psoriatic arthritis	0.000116	0.003	CcSEcCtD
Metoclopramide—Tachycardia—Betamethasone—psoriatic arthritis	0.000116	0.003	CcSEcCtD
Metoclopramide—Angioedema—Prednisone—psoriatic arthritis	0.000116	0.00299	CcSEcCtD
Metoclopramide—Urticaria—Prednisolone—psoriatic arthritis	0.000113	0.00292	CcSEcCtD
Metoclopramide—Fatigue—Triamcinolone—psoriatic arthritis	0.000113	0.00292	CcSEcCtD
Metoclopramide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000113	0.00291	CcSEcCtD
Metoclopramide—Hypotension—Betamethasone—psoriatic arthritis	0.000111	0.00287	CcSEcCtD
Metoclopramide—Hypotension—Dexamethasone—psoriatic arthritis	0.000111	0.00287	CcSEcCtD
Metoclopramide—Convulsion—Prednisone—psoriatic arthritis	0.00011	0.00284	CcSEcCtD
Metoclopramide—Hypertension—Prednisone—psoriatic arthritis	0.000109	0.00283	CcSEcCtD
Metoclopramide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000108	0.00279	CcSEcCtD
Metoclopramide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000108	0.00278	CcSEcCtD
Metoclopramide—Anxiety—Prednisone—psoriatic arthritis	0.000107	0.00278	CcSEcCtD
Metoclopramide—Insomnia—Betamethasone—psoriatic arthritis	0.000107	0.00278	CcSEcCtD
Metoclopramide—Insomnia—Dexamethasone—psoriatic arthritis	0.000107	0.00278	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000105	0.00271	CcSEcCtD
Metoclopramide—Urticaria—Triamcinolone—psoriatic arthritis	0.000104	0.00269	CcSEcCtD
Metoclopramide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000104	0.00268	CcSEcCtD
Metoclopramide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000103	0.00268	CcSEcCtD
Metoclopramide—Oedema—Prednisone—psoriatic arthritis	0.000103	0.00267	CcSEcCtD
Metoclopramide—Fatigue—Dexamethasone—psoriatic arthritis	0.000102	0.00265	CcSEcCtD
Metoclopramide—Fatigue—Betamethasone—psoriatic arthritis	0.000102	0.00265	CcSEcCtD
Metoclopramide—Tachycardia—Prednisone—psoriatic arthritis	0.000101	0.00261	CcSEcCtD
Metoclopramide—Feeling abnormal—Dexamethasone—psoriatic arthritis	9.78e-05	0.00253	CcSEcCtD
Metoclopramide—Feeling abnormal—Betamethasone—psoriatic arthritis	9.78e-05	0.00253	CcSEcCtD
Metoclopramide—Hypersensitivity—Triamcinolone—psoriatic arthritis	9.64e-05	0.00249	CcSEcCtD
Metoclopramide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	9.61e-05	0.00249	CcSEcCtD
Metoclopramide—Leukopenia—Methotrexate—psoriatic arthritis	9.47e-05	0.00245	CcSEcCtD
Metoclopramide—Urticaria—Dexamethasone—psoriatic arthritis	9.43e-05	0.00244	CcSEcCtD
Metoclopramide—Urticaria—Betamethasone—psoriatic arthritis	9.43e-05	0.00244	CcSEcCtD
Metoclopramide—Dizziness—Prednisolone—psoriatic arthritis	9.4e-05	0.00243	CcSEcCtD
Metoclopramide—Asthenia—Triamcinolone—psoriatic arthritis	9.38e-05	0.00243	CcSEcCtD
Metoclopramide—Body temperature increased—Betamethasone—psoriatic arthritis	9.38e-05	0.00243	CcSEcCtD
Metoclopramide—Body temperature increased—Dexamethasone—psoriatic arthritis	9.38e-05	0.00243	CcSEcCtD
Metoclopramide—Asthenia—Methylprednisolone—psoriatic arthritis	9.36e-05	0.00242	CcSEcCtD
Metoclopramide—Insomnia—Prednisone—psoriatic arthritis	9.35e-05	0.00242	CcSEcCtD
Metoclopramide—Convulsion—Methotrexate—psoriatic arthritis	9.17e-05	0.00237	CcSEcCtD
Metoclopramide—Rash—Prednisolone—psoriatic arthritis	8.97e-05	0.00232	CcSEcCtD
Metoclopramide—Dermatitis—Prednisolone—psoriatic arthritis	8.96e-05	0.00232	CcSEcCtD
Metoclopramide—Diarrhoea—Methylprednisolone—psoriatic arthritis	8.93e-05	0.00231	CcSEcCtD
Metoclopramide—Fatigue—Prednisone—psoriatic arthritis	8.91e-05	0.00231	CcSEcCtD
Metoclopramide—Headache—Prednisolone—psoriatic arthritis	8.91e-05	0.00231	CcSEcCtD
Metoclopramide—Confusional state—Methotrexate—psoriatic arthritis	8.71e-05	0.00225	CcSEcCtD
Metoclopramide—Dizziness—Triamcinolone—psoriatic arthritis	8.65e-05	0.00224	CcSEcCtD
Metoclopramide—Dizziness—Methylprednisolone—psoriatic arthritis	8.63e-05	0.00223	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisone—psoriatic arthritis	8.52e-05	0.0022	CcSEcCtD
Metoclopramide—Asthenia—Dexamethasone—psoriatic arthritis	8.51e-05	0.0022	CcSEcCtD
Metoclopramide—Asthenia—Betamethasone—psoriatic arthritis	8.51e-05	0.0022	CcSEcCtD
Metoclopramide—Nausea—Prednisolone—psoriatic arthritis	8.45e-05	0.00219	CcSEcCtD
Metoclopramide—Rash—Triamcinolone—psoriatic arthritis	8.25e-05	0.00213	CcSEcCtD
Metoclopramide—Dermatitis—Triamcinolone—psoriatic arthritis	8.24e-05	0.00213	CcSEcCtD
Metoclopramide—Rash—Methylprednisolone—psoriatic arthritis	8.23e-05	0.00213	CcSEcCtD
Metoclopramide—Dermatitis—Methylprednisolone—psoriatic arthritis	8.22e-05	0.00213	CcSEcCtD
Metoclopramide—Urticaria—Prednisone—psoriatic arthritis	8.21e-05	0.00212	CcSEcCtD
Metoclopramide—Headache—Triamcinolone—psoriatic arthritis	8.19e-05	0.00212	CcSEcCtD
Metoclopramide—Headache—Methylprednisolone—psoriatic arthritis	8.17e-05	0.00212	CcSEcCtD
Metoclopramide—Body temperature increased—Prednisone—psoriatic arthritis	8.17e-05	0.00211	CcSEcCtD
Metoclopramide—Diarrhoea—Betamethasone—psoriatic arthritis	8.12e-05	0.0021	CcSEcCtD
Metoclopramide—Diarrhoea—Dexamethasone—psoriatic arthritis	8.12e-05	0.0021	CcSEcCtD
Metoclopramide—Hypotension—Methotrexate—psoriatic arthritis	8.07e-05	0.00209	CcSEcCtD
Metoclopramide—Dizziness—Betamethasone—psoriatic arthritis	7.85e-05	0.00203	CcSEcCtD
Metoclopramide—Dizziness—Dexamethasone—psoriatic arthritis	7.85e-05	0.00203	CcSEcCtD
Metoclopramide—Insomnia—Methotrexate—psoriatic arthritis	7.81e-05	0.00202	CcSEcCtD
Metoclopramide—Nausea—Triamcinolone—psoriatic arthritis	7.77e-05	0.00201	CcSEcCtD
Metoclopramide—Nausea—Methylprednisolone—psoriatic arthritis	7.75e-05	0.00201	CcSEcCtD
Metoclopramide—Dyspnoea—Methotrexate—psoriatic arthritis	7.7e-05	0.00199	CcSEcCtD
Metoclopramide—Somnolence—Methotrexate—psoriatic arthritis	7.68e-05	0.00199	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisone—psoriatic arthritis	7.61e-05	0.00197	CcSEcCtD
Metoclopramide—Rash—Dexamethasone—psoriatic arthritis	7.48e-05	0.00194	CcSEcCtD
Metoclopramide—Rash—Betamethasone—psoriatic arthritis	7.48e-05	0.00194	CcSEcCtD
Metoclopramide—Dermatitis—Betamethasone—psoriatic arthritis	7.48e-05	0.00193	CcSEcCtD
Metoclopramide—Dermatitis—Dexamethasone—psoriatic arthritis	7.48e-05	0.00193	CcSEcCtD
Metoclopramide—Fatigue—Methotrexate—psoriatic arthritis	7.45e-05	0.00193	CcSEcCtD
Metoclopramide—Headache—Dexamethasone—psoriatic arthritis	7.43e-05	0.00192	CcSEcCtD
Metoclopramide—Headache—Betamethasone—psoriatic arthritis	7.43e-05	0.00192	CcSEcCtD
Metoclopramide—Asthenia—Prednisone—psoriatic arthritis	7.41e-05	0.00192	CcSEcCtD
Metoclopramide—Feeling abnormal—Methotrexate—psoriatic arthritis	7.12e-05	0.00184	CcSEcCtD
Metoclopramide—Diarrhoea—Prednisone—psoriatic arthritis	7.07e-05	0.00183	CcSEcCtD
Metoclopramide—Nausea—Betamethasone—psoriatic arthritis	7.05e-05	0.00182	CcSEcCtD
Metoclopramide—Nausea—Dexamethasone—psoriatic arthritis	7.05e-05	0.00182	CcSEcCtD
Metoclopramide—Urticaria—Methotrexate—psoriatic arthritis	6.86e-05	0.00178	CcSEcCtD
Metoclopramide—Dizziness—Prednisone—psoriatic arthritis	6.83e-05	0.00177	CcSEcCtD
Metoclopramide—Body temperature increased—Methotrexate—psoriatic arthritis	6.83e-05	0.00177	CcSEcCtD
Metoclopramide—Rash—Prednisone—psoriatic arthritis	6.52e-05	0.00169	CcSEcCtD
Metoclopramide—Dermatitis—Prednisone—psoriatic arthritis	6.51e-05	0.00168	CcSEcCtD
Metoclopramide—Headache—Prednisone—psoriatic arthritis	6.47e-05	0.00168	CcSEcCtD
Metoclopramide—Hypersensitivity—Methotrexate—psoriatic arthritis	6.36e-05	0.00165	CcSEcCtD
Metoclopramide—Asthenia—Methotrexate—psoriatic arthritis	6.2e-05	0.0016	CcSEcCtD
Metoclopramide—Nausea—Prednisone—psoriatic arthritis	6.14e-05	0.00159	CcSEcCtD
Metoclopramide—Diarrhoea—Methotrexate—psoriatic arthritis	5.91e-05	0.00153	CcSEcCtD
Metoclopramide—Dizziness—Methotrexate—psoriatic arthritis	5.71e-05	0.00148	CcSEcCtD
Metoclopramide—Rash—Methotrexate—psoriatic arthritis	5.45e-05	0.00141	CcSEcCtD
Metoclopramide—Dermatitis—Methotrexate—psoriatic arthritis	5.44e-05	0.00141	CcSEcCtD
Metoclopramide—Headache—Methotrexate—psoriatic arthritis	5.41e-05	0.0014	CcSEcCtD
Metoclopramide—Nausea—Methotrexate—psoriatic arthritis	5.13e-05	0.00133	CcSEcCtD
